Lataa...
Immuno-targeting of pancreatic cancer stem cells: A new therapeutic strategy against a devastating disease?
Pancreatic cancer is a highly aggressive and deadly disease harboring a distinct population of cancer stem cells (CSC) that is not affected by conventional therapies. A new therapeutic approach using the EpCAM/CD3-bispecific antibody MT110 is capable of activating and redirecting cytotoxic T cells t...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Landes Bioscience
2012
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3382890/ https://ncbi.nlm.nih.gov/pubmed/22754787 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|